The city of Shreveport, Louisiana, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Gender:
All
Ages:
40 years and above
Trial Updated:
06/04/2024
Locations: LSU Health Science Center Shreveport, Shreveport, Louisiana
Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease